Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Sell
15,024
-7,521
-33% -$880K 0.06% 232
2026
Q1
$2.71M Buy
22,545
+326
+1% +$37.6K 0.1% 171
2025
Q4
$2.34M Buy
22,219
+10,837
+95% +$1.02M 0.09% 187
2025
Q3
$955K Buy
11,382
+2,500
+28% +$206K 0.04% 261
2025
Q2
$703K Sell
8,882
-16,295
-65% -$1.3M 0.04% 260
2025
Q1
$2.26M Buy
25,177
+19,818
+370% +$1.85M 0.09% 173
2024
Q4
$533K Buy
+5,359
New +$552K 0.06% 131

Other funds holding MRK

Integrity Alliance's MRK Position: Q2 2026 in Review

Integrity Alliance reduced its Merck (MRK) stake by 33% in Q2 2026, selling an estimated $880K and leaving 15,024 shares worth $1.93M. The position accounts for 0.06% of the portfolio, ranked #232.

Integrity Alliance first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.71M in Q1 2026. 2,468 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Integrity Alliance held 15,024 shares of Merck worth $1.93M as of Q2 2026.
  • Integrity Alliance sold 7,521 Merck shares in Q2 2026, an estimated $880K.
  • Merck made up 0.06% of Integrity Alliance's portfolio in Q2 2026, its #232 holding.
  • Integrity Alliance first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Integrity Alliance's Merck position peaked at $2.71M in Q1 2026.
  • 2,468 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.